TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06614361

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination
Study: NCT06710587

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Voy Program
Description: Voy Program - coaching and access to the Voy app to support behavioural changes
Study: NCT06708676

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Washed Microbiota Transplantation
Description: Washed microbiota suspension delivered through mild-gut and lower-gut
Study: NCT06710340

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Nuts in the first meeting
Description: 30g of walnuts

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nuts in the second meeting
Description: 30g of walnuts
Study: NCT06614361

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lottery prize for vaccination
Description: Modest lottery prize for COVID vaccination
Study: NCT06710327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (IV)
Description: The intervention is administered as a clear, colorless solution infusion. The dosage administered is a 1 gram intravenous (IV) push, delivered immediately before starting the Aquablation therapy. The administration of TXA occurs only once, as a single dose preoperatively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants receive a saline solution, which is a sodium chloride (0.9%) IV infusion, identical in appearance to the TXA solution. The saline is administered as a single 1 gram-equivalent volume intravenous (IV) push, delivered immediately before the Aquablation therapy commences. This singular administration matches the frequency and timing of the TXA intervention to ensure uniformity across both study groups, maintaining the blinding of the study.
Study: NCT06707857

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tendon neuroplastic training
Description: Throughout the training, participants pain, range of motion and disability were monitored and they were asked to report any discomfort or unusual sign.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional training
Description: Throughout the training, participants pain, range of motion and disability were monitored and they were asked to report any discomfort or unusual sign.
Study: NCT06708637

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FYB203 2 mg (0.05 mL of 40 mg/mL)
Description: IVT administration of FYB203 in a PFS
Study: NCT06300762

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Superabsorbent dressing application
Description: Cutimed Sorbion or Zetuvit plus (RespoSorb) application to maintain wound exudate

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Superabsorbent dressing application
Description: Cutimed Sorbion or Zetuvit plus (RespoSorb) application to maintain wound exudate
Study: NCT06614361

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).
Study: NCT06710938

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The system includes the G-Branch™ thoracoabdominal aortic stent graft system, the peripheral vascular stent graft system, and the aortic extension stent graft system
Description: The thoracoabdominal artery stent graft system is a mixed branch design with two inner branches for the visceral arteries and two outer branches for the bilateral renal arteries.
Study: NCT06709755

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supporting Teen Problem Solving
Description: STePS is a group-based, teen-focused intervention aimed at reducing diabetes-specific emotional distress and building diabetes resilience. STePS is grounded in both cognitive-behavioral and social problem-solving theories, which recognize the interrelationships among difficult situations, beliefs related to the cause and consequences of those situations, and the emotional and behavioral consequences of those beliefs, and which addresses problem solving strategies that influences ones' adaptive functioning in real-life social settings, distinguishing between problem solving and solution implementation. STePS reduces distress by teaching: 1) emotion regulation, helping teens learn to link beliefs, emotions, and behaviors; to challenge negative thinking by evaluating the accuracy of one's beliefs; and learning new coping skills.2) perspective taking, helping teens learn to identify their own thinking style.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supporting Teen Problem Solving
Description: STePS is a group-based, teen-focused intervention aimed at reducing diabetes-specific emotional distress and building diabetes resilience. STePS is grounded in both cognitive-behavioral and social problem-solving theories, which recognize the interrelationships among difficult situations, beliefs related to the cause and consequences of those situations, and the emotional and behavioral consequences of those beliefs, and which addresses problem solving strategies that influences ones' adaptive functioning in real-life social settings, distinguishing between problem solving and solution implementation. STePS reduces distress by teaching: 1) emotion regulation, helping teens learn to link beliefs, emotions, and behaviors; to challenge negative thinking by evaluating the accuracy of one's beliefs; and learning new coping skills.2) perspective taking, helping teens learn to identify their own thinking style.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Education
Description: Arm Description: The Participants will receive diabetes education directed toward adolescents matching time, group experience and homework assignments, delivered virtually
Study: NCT06708195

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Group experimental
Description: Type: Inactive TENS (placebo) Frequency: 1 session Session duration: 15 minutes Application area: Skin over the bilateral parotid glan

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group experimental
Description: Type: Inactive TENS (placebo) Frequency: 1 session Session duration: 15 minutes Application area: Skin over the bilateral parotid glan
Study: NCT06710314

Intervention type: DIAGNOSTIC_TEST
Intervention: Colorectal cancer patients with hypertension
Description: Colorectal cancer patients with hypertension

Intervention type: DIAGNOSTIC_TEST
Intervention: Colorectal cancer patients with diabetes
Description: Colorectal cancer patients with diabetes

Intervention type: DIAGNOSTIC_TEST
Intervention: Colorectal cancer patients with fatty liver
Description: Colorectal cancer patients with fatty liver
Study: NCT06708403

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Judo-Specific Injury Prevention Exercise Program
Description: The intervention includes a structured program designed specifically for judo athletes to prevent injuries and enhance performance. The program consists of warm-up exercises, strength and conditioning drills, balance improvement exercises, agility training, and sport-specific movements. It is delivered over six weeks, with participants completing three sessions per week. Each session is progressively tailored to improve overall motor skills, prevent overuse injuries, and enhance judo-specific abilities.
Study: NCT06706791

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Empagliflozin 10 MG
Description: participants will be divided in two groups one group will empagliflozin 10mg once daily along with standard treatment secong group receiving placebo once daily along with standard treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: participants will be divided in two groups one group will empagliflozin 10mg once daily along with standard treatment secong group receiving placebo once daily along with standard treatment.
Study: NCT06709170

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novel asymmetrical linear stapler
Description: Novel asymmetrical linear stapler

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Signia™
Description: Signia™
Study: NCT06709794

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Informational flyer
Description: In addition to a standard eligibility notice informing participants of their eligibility for marketplace coverage, they receive an informational flyer describing what Covered California is, the availability of financial assistance, and information on benefit design and private insurance terminology, such as deductibles and copays

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified eligibility notice with plan information
Description: a modified eligibility notice that includes information on the pre-selected lowest-cost silver health insurance plan with a personalized quote for their net premium amount in addition to the informational flyer and instead of a standard eligibility notice
Study: NCT05629546

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cytokine-induced memory-like natural killer cells
Description: Cell product processing is performed at the Siteman Cancer Center Biological Therapy Core Facility (BTCF).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cytokine-induced memory-like natural killer cells
Description: Cell product processing is performed at the Siteman Cancer Center Biological Therapy Core Facility (BTCF).
Study: NCT04877015

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Vibrotactile Coordinated Reset (vCR)
Description: Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Vibrotactile Coordinated Reset (vCR)
Description: Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. An inactive pattern of vibration to each fingertip is delivered which theoretically will not have the effects of active vCR.
Study: NCT05629546

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Relatilmab
Description: Standard of care

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Relatilmab
Description: Standard of care

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Standard of care

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Standard of care
Study: NCT05796193

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alpha-cypermethrin and PBO LLIN
Description: Veeralin Long lasting insecticidal net with Alpha-cypermethrin Pyrethroid insecticide and PBO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alpha-cypermethrin and Clorfenapyr LLIN
Description: Interceptor G2 dual active ingredient LLIN with with Alpha-cypermethrin Pyrethroid insecticide and Clorfenapyr

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alpha-cypermethrin only LLIN
Description: reference: standard pyrethroid LLIN
Study: NCT04893811

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trumenba
Description: Bivalent recombinant lipoprotein 2086 vaccine
Study: NCT06369155

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azenosertib
Description: Wee1 inhibitor, 25mg and 100mg tablets, taken orally per protocol.
Study: NCT05526157

Intervention type: DRUG
Intervention: Finerenone (Kerendia, BAY 948862)
Description: Retrospective analysis using secondary data collection from various sources

Intervention type: DRUG
Intervention: Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Description: Retrospective analysis using secondary data collection from various sources

Intervention type: DRUG
Intervention: Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Description: Retrospective analysis using secondary data collection from various sources
Study: NCT06614361

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation
Description: Peer navigation (4 months duration, contact as needed).
Study: NCT06614283

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetes self management @ click
Description: A mobile application tailored for patients with Type 2 diabetes, aiming to enhance their self-management practices will be used for the intervention arm. The app includes features such as medication tracking, appointment scheduling, patient data storage, advice for treatment and follow-ups, health education and promotion, and real-time health monitoring.
Study: NCT06615297

Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasonographic evaluation
Description: facial nerve thickness (right/left), depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated.
Study: NCT06615089

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: balance training
Description: the elderly patients will receive balance training in the form of proprioceptive and vestibular training components. proprioceptive training include Standing static balance, lateral weight transfer, Lateral weight transfer near to chair, tandem closed eyes, walking on toes, Postural control using ball. Vestibular training in the form of Balance with head movement, seated lateral step in addition to Insoles inside the subjects' own regular shoes

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: orthotic prescription
Description: the elderly patients will receive Insoles inside the subjects' own regular shoes

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: orthotic prescription
Description: the elderly patients will receive Insoles inside the subjects' own regular shoes
Study: NCT06615362

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: preparation of dentin membrane from hopeless tooth for Guided Bone Regeneration in Immediate Implant
Description: tooth extraction , preparation of dentin membrane ,immediate implantation ,Xenogeneic bone graft material, application of dentin derived barrier membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Collagen Membrane for Guided Bone Regeneration in Immediate Implant
Description: like group one but with application of collagen membrane
Study: NCT06614439

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: proximal gastrectomy
Description: proximal gastrectomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: total gastrectomy
Description: total gastrectomy
Study: NCT05642507

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AC01
Description: AC01 microtablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AC01
Description: AC01 microtablets
Study: NCT06169852

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unilateral dual-target (STN/GPi) DBS
Description: Participants will be randomly assigned either DBS stimulation in the STN alone, GPi alone, or a combination of stimulation in the STN and GPi.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unilateral dual-target (STN/GPi) DBS
Description: Participants will be randomly assigned either DBS stimulation in the STN alone, GPi alone, or a combination of stimulation in the STN and GPi.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unilateral dual-target (STN/GPi) DBS
Description: Participants will be randomly assigned either DBS stimulation in the STN alone, GPi alone, or a combination of stimulation in the STN and GPi.
Study: NCT06614413

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Neurodevelopment and behaviour assesment 2 years old
Description: Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurodevelopment and behaviour assesment 2 years old
Description: Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age
Study: NCT06614621

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab +Etoposide+Platinum-based drugs
Description: Adebrelimab：20mg/kg或1200mg ivgtt ，d1 ，Q3W Etoposide injection (E): 100mg/m2, ivgtt, d1,d2,d3,Q3W Platinum-based drugs：75mg/m2， ivgtt， d1,d2,d3,Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maintenance treatment period:
Description: Adebrelimab：20mg/kg或1200mg，IV, Q3W； Apatinib Mesylate Tablets：250mg，P.O，qod
Study: NCT06614530

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chilipad Docker Pro
Description: The Chilipad Dock Pro is an advanced sleep system designed to optimize sleep by dynamically adjusting the bed\&#39;s surface temperature. It consists of a mesh mattress pad and a Dock Pro control unit that circulates water through the pad, allowing users to customize the temperature between 55°F and 115°F. The system offers both single and dual control, making it ideal for individual or shared use. Equipped with AI-driven features, the Dock Pro can monitor sleep patterns and environmental factors to make real-time adjustments, ensuring optimal sleep conditions throughout the night. This intelligent temperature management system is enhanced when paired with the optional Sleepme Tracker, creating a personalized sleep experience.
Study: NCT06527768

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Theory-based health behaviour change interventio
Description: The online individual education sessions are related to MetS, CKD, healthy dietary and PA, displayed in the form of texts and pictures, and online instant conversations via WeChat. The online group music-paced brisk walking training includes a 5-minute warm-up, 30-minute music-paced brisk walking, and 5-minute stretching exercises to promote cool-down. The group discussion is related to current health status, recommended dietary regimens, and exercise and personal goals. The telephone follow-up after the group discussion is to reinforce the predetermined goals and the practice of healthy dietary and music-paced brisk walking, and to provide opportunities for answering any questions related to the practice of healthy dietary and music-paced brisk walking. All the education session contents are based on a well-structured health handbook. The self-music-paced brisk walking is required to be performed for 30 minutes/day, 5 days/week.
Study: NCT06668740

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The use of Virtual Reality Glasses in Elderly
Description: The group first completed a pretest, after which they watched 360-degree VR videos, such as nature walks and trips, for 10 minutes once a week over four weeks. Following this, a posttest was conducted. The outcomes will be used to measure changes in Quality of Life.
Study: NCT05706025

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EnteroTracker
Description: The EnteroTracker® is a capsule device that includes an absorbent string.
Study: NCT06615115

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All participants will perform a total body stretching exercise for 10 minutes, followed by 10 minutes of obstacle course navigation, 10 minutes of balance training (including tandem walking, balance board exercises, single-leg balance, and two-legged reaching exercises), and will conclude with 10 minutes of strength training exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All participants will perform a total body stretching exercise for 10 minutes, followed by 10 minutes of obstacle course navigation, 10 minutes of balance training (including tandem walking, balance board exercises, single-leg balance, and two-legged reaching exercises), and will conclude with 10 minutes of strength training exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All participants will perform a total body stretching exercise for 10 minutes, followed by 10 minutes of obstacle course navigation, 10 minutes of balance training (including tandem walking, balance board exercises, single-leg balance, and two-legged reaching exercises), and will conclude with 10 minutes of strength training exercises.
Study: NCT06614569

Intervention type: DRUG
Intervention: AXO-AAV-GM2
Description: Participants who received AXO-AAV-GM2 will be tracked in long term follow up
Study: NCT05870930

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carob beverage
Description: Volunteers will consume 2 tablespoons of carob powder in 200mL drinking water.
Study: NCT06249711

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active stimulation with Diadem ultrasonic transducer array
Description: Diadem ultrasonic transducer array delivers focused low-intensity ultrasound stimulation

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation with Diadem ultrasonic transducer array
Description: Diadem ultrasonic transducer array delivers focused zero-intensity ultrasound stimulation